136
Participants
Start Date
March 2, 2025
Primary Completion Date
October 25, 2026
Study Completion Date
November 15, 2026
Gabapentin (Neurontin® (Registered Trademark))
Additionally, during this phase, patients will be educated on how to report their perceived pain, rated from 0 to 10 on the visual analog scale (VAS). Subsequently, another dedicated pain-management specialist will engage with each patient to formulate and document an individualized pain management plan, taking into consideration the patient's medical history, previous pain experiences, and preferences for pain management strategies. As part of preemptive analgesia, patients receive 300 mg of gabapentin orally 2 hours prior to surgery, unless contraindicated.
Hawler Medical University/College of nursing, Erbil
Haroon Muhammad Khalil
OTHER